Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-term efficacy of adalimumab after drug withdrawal and retreatment in patients with active non-radiographically evident axial spondyloarthritis who experience a flare.

× No keyword cloud information.

11 in total

Review 1. New evidence on the management of spondyloarthritis.

Authors: Joachim Sieper; Denis Poddubnyy
Journal: Nat Rev Rheumatol Date: 2016-04-07 Impact factor: 20.543

Review 2. Understanding the paradigm of non-radiographic axial spondyloarthritis.

Authors: Diego Benavent; Victoria Navarro-Compán
Journal: Clin Rheumatol Date: 2020-09-29 Impact factor: 2.980

Review 3. Tumor necrosis factor-α (TNFα) inhibitors in the treatment of nonradiographic axial spondyloarthritis: current evidence and place in therapy.

Authors: Valeria Rios Rodriguez; Denis Poddubnyy
Journal: Ther Adv Musculoskelet Dis Date: 2017-05-09 Impact factor: 5.346

Review 4. Treatment challenges in axial spondylarthritis and future directions.

Authors: Joachim Sieper
Journal: Curr Rheumatol Rep Date: 2013-09 Impact factor: 4.592

Review 5. Value-Based Healthcare in Rheumatology: Axial Spondyloarthritis and Beyond.

Authors: David F L Liew; Jonathan Dau; Philip C Robinson
Journal: Curr Rheumatol Rep Date: 2021-04-28 Impact factor: 4.592

Review 6. Anti-TNFs in axial spondyloarthritis.

Authors: Roland Kocijan; Christian Muschitz; Jürgen Rech
Journal: Wien Med Wochenschr Date: 2015-01-09

7. Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.

Authors: Alexandre Sepriano; Andrea Regel; Désirée van der Heijde; Jürgen Braun; Xenofon Baraliakos; Robert Landewé; Filip Van den Bosch; Louise Falzon; Sofia Ramiro
Journal: RMD Open Date: 2017-01-27

8. Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study.

Authors: Mireia Moreno; Jordi Gratacós; Vicenç Torrente-Segarra; Raimon Sanmarti; Rosa Morlà; Caridad Pontes; Maria Llop; Xavier Juanola
Journal: Arthritis Res Ther Date: 2019-04-05 Impact factor: 5.156

Review 9. Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis.

Authors: James Cheng-Chung Wei; Chin-Hsiu Liu; Jui-Cheng Tseng; Lin-Fen Hsieh; Chun-Hsiung Chen; Hsin-Hua Chen; Hung-An Chen; Ying-Chou Chen; Chung-Tei Chou; Hsien-Tzung Liao; Yi-Chun Lin; Shue-Fen Luo; Deng-Ho Yang; Kai-Jieh Yeo; Wen-Chan Tsai
Journal: Int J Rheum Dis Date: 2019-11-27 Impact factor: 2.454

10. Multi-target mechanism of Tripteryguim wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking.

Authors: Jing Zhang; Yiting Zhou; Zhiyuan Ma
Journal: Ann Med Date: 2021-12 Impact factor: 4.709